The DOI matches its Crossref record; 209 of the 210 references it cites were found in a registry or an index.
Recent advances with liposomes as pharmaceutical carriers
Abstract
Liposomes - microscopic phospholipid bubbles with a bilayered membrane structure - have received a lot of attention during the past 30 years as pharmaceutical carriers of great potential. More recently, many new developments have been seen in the area of liposomal drugs - from clinically approved products to new experimental applications, with gene delivery and cancer therapy still being the principal areas of interest. For further successful development of this field, promising trends must be identified and exploited, albeit with a clear understanding of the limitations of these approaches.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Liposomes are amphiphilic in nature and are composed of natural or synthetic lipids.237”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [237]
Citations
Cites
Cellular uptake of the tat protein from human immunodeficiency virus
Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,782
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,030
Self-citationWadia, J. S., Stan, R. V., & Dowdy, S. F. (2004) · Nature Medicine · doi:10.1038/nm996 · Cited by 1,647
Liposomes: From Physics to Applications
Lasiç, D. D. (1993) · Cited by 1,304
Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,228
Cationic liposome-mediated transfection
Felgner, P. L., & RINGOLD, G. M. (1989) · Nature · doi:10.1038/337387a0 · Cited by 989
Folate-mediated delivery of macromolecular anticancer therapeutic agents
Lu, Y. J., & Low, P. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00042-x · Cited by 942
Maeda, H., Sawa, T., & Konno, T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00309-1 · Cited by 926
Torchilin, V. P., Rammohan, R., Weissig, V., & Levchenko, T. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151247498 · Cited by 777
Self-citationLipid vesicles and other colloids as drug carriers on the skin
Cevc, G. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.028 · Cited by 703
Flagged first, then by citations
1 of the 210 references couldn’t be matched to a known paper.
Research works printed but not linked: 11
- Stealth® Liposomes, Chapter 19 (eds Martin, F. & Lasic, D.) 225–237 (CRC Press, Boca Raton, 1995).
- Torchilin, V. P. & Klibanov, A. L. in Phospholipid Handbook (ed. Cevc, G.) 293–321 (Marcel Dekker, New York, 1993).
- Tu, R., Mohanty, K. & Tirrell, M. Liposomal targeting through peptide-amphiphile functionalization. Pharm. Rev. 7, 36–41 (2004)
- Li, H., Song, J. H., Park, J. S. & Han, K. Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor. Int. J. Pharm. 258, 11–19 (2003). · DOI
- Lo, Y. L., Tsai, J. C. & Kuo, J. H. Liposomes and disaccharides as carriers in spray-dried powder formulations of superoxide dismutase. J. Control. Release 94, 259–272 (2004). · DOI
- Chikh, G. & Schutze-Redelmeier, M. P. Liposomal delivery of CTL epitopes to dendritic cells. Biosci. Rep. 22, 339–353 (2002). · DOI
- Chikh, G. G., Kong, S., Bally, M. B., Meunier, J. C. & Schutze-Redelmeier, M. P. Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells. J. Immunol. 167, 6462–6470 (2001). · DOI
- Copland, M. J. et al. Liposomal delivery of antigen to human dendritic cells. Vaccine 21, 883–890 (2003). · DOI
- Tilcock, C. in Liposomes as Tools in Basic Research and Industry (eds Philippot, J. R. & Schuber, F.) 225–240 (CRC, Boca Raton, 1995).
- Gregoriadis, G. (ed.). Liposome Technology vol. 1–3 (CRC, Boca Raton, 1984).
- Martin, F. & Lasic, D. (eds.). Stealth Liposomes (CRC, Boca Raton, 1995).
Cited by
Sorted by citations
Items 1,001–1,016 of 1,016
Hussain, S., Plückthun, A., Allen, T. M., & Zangemeister‐Wittke, U. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0615 · Cited by 89
Axial pharmaceutical properties of liposome in cancer therapy: Recent advances and perspectives
Kiaie, S. H., Mojarad-Jabali, S., Khaleseh, F., Allahyari, S., Taheri, E., Zakeri-Milani, P., & Valizadeh, H. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119269 · Cited by 87
Nanoparticle-Mediated Drug Delivery System for Cardiovascular Disease
Matoba, T., & Egashira, K. (2014) · International Heart Journal · doi:10.1536/ihj.14-150 · Cited by 83
Polymeric micelles for enhanced lymphatic drug delivery to treat metastatic tumors
Qin, L., Zhang, F., Lu, X., Wei, X., Wang, J., Fang, X., Si, D., Wang, Y., Zhang, C., Yang, R., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.005 · Cited by 80
Skajaa, T., Zhao, Y., van den Heuvel, D. J., Gerritsen, H. C., Cormode, D. P., Koole, R., van Schooneveld, M. M., Post, J. A., Fisher, E. A., Fayad, Z. A., et al. (2010) · Nano Letters · doi:10.1021/nl1037903 · Cited by 76
Li, L., Wang, J., Kong, H., Zeng, Y., & Liu, G. (2018) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2018.1528850 · Cited by 71
Li, Z., Liu, M., Ke, L., Wang, L.-J., Wu, C., Li, C., Li, Z., & Wu, Y.-L. (2021) · Nanoscale Advances · doi:10.1039/d1na00596k · Cited by 59
Prabhu, S., Goda, J. S., Mutalik, S., Mohanty, B. S., Chaudhari, P., Rai, S., Udupa, N., & Rao, B. S. S. (2017) · Nanoscale · doi:10.1039/c7nr00305f · Cited by 54
Liposomes as lubricants: beyond drug delivery
Goldberg, R., & Klein, J. (2012) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.11.007 · Cited by 53
Ligand-functionalized nanoliposomes for targeted delivery of galantamine
Mufamadi, M. S., Choonara, Y. E., Kumar, P., Modi, G., Naidoo, D., van Vuuren, S., Ndesendo, V. M. K., Toit, L. C. D., Iyuke, S. E., & Pillay, V. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.037 · Cited by 51
Kim, H., Seo, E.-H., Lee, S.-H., & Kim, B.-J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122054 · Cited by 48
Dual-pH responsive micelle platform for co-delivery of axitinib and doxorubicin
Xu, X., Li, L., Zhou, Z., Sun, W., & Huang, Y. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.060 · Cited by 41
Gupta, A., Kaur, C. D., Saraf, S., & Saraf, S. (2017) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2016.1147581 · Cited by 27
Biocompatible Nanovesicular Drug Delivery Systems with Targeting Potential for Autoimmune Diseases
Neupane, Y. R., Mahtab, A., Siddiqui, L., Singh, A., Gautam, N., Rabbani, S. A., Goel, H., & Talegaonkar, S. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200523174108 · Cited by 21
In Vitro and In Vivo Study of Amphotericin B Formulation with Quaternized Bioreducible Lipidoids
Liu, F., Yang, L., Li, Y., Junier, A., Ma, F., Chen, J., Han, H., Glass, Z., Zhao, X., Kumamoto, C. A., et al. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01722 · Cited by 21
Evolution of prime editing systems: move forward to the treatment of hereditary diseases
Volodina, O. V., Fabrichnikova, A. R., Anuchina, A. A., Mishina, O. S., Lavrov, A. V., & Smirnikhina, S. A. (2025) · Current Gene Therapy · doi:10.2174/0115665232295117240405070809 · Cited by 1
Metadata
- Authors
- Torchilin, V. P.
- Affiliations
- Northeastern University (US)
- Corresponding author
- Torchilin, Vladimir P.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-02
- Volume
- 4
- Issue
- 2
- Pages
- 145-160
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2061510929
- Cited by
- 5,282
- References
- 210
- Citations by year
- 2026: 183 · 2025: 227 · 2024: 217 · 2023: 222 · 2022: 284 · 2021: 252 · 2020: 311 · 2019: 275 · 2018: 274 · 2017: 302 · 2016: 343 · 2015: 324 · 2014: 368 · 2013: 334 · 2012: 351
- FWCI
- 7.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- liposomes, drug carriers, liposomal drugs, gene delivery, cancer therapy, phospholipid bilayers, drug delivery systems
- MeSH terms
- Animals, Humans, Liposomes, Technology, Pharmaceutical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
